相关实验视频

Updated: Jul 5, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

在SAH中药疗:临床试验教训

Sotirios Apostolakis^1,2, Pantelis Stavrinou²

¹Department of Neurosurgery, KAT General Hospital of Attica, Kifisia, Greece.

CNS & neurological disorders drug targets

|January 20, 2024

概括

副关节出血 (SAH) 药物治疗已经发展,尼莫迪平是唯一基于证据的血管治疗方法. 新兴的药物和疗法显示出改善SAH患者结果的希望.

科学领域:

神经学神经学
药理学药理学是指药理学的学科.

背景情况:

下关节下出血 (SAH) 是一种关键的神经紧急情况.
在SAH的手术和药物治疗方面取得了重大进展.
药物治疗在管理SAH并发症和改善患者预后方面发挥着至关重要的作用.

研究的目的:

审查目前在SAH药物治疗中的最佳实践.
总结最近对SAH治疗的临床试验中新出现的证据.
提供新型治疗剂和SAH管理策略的概述.

主要方法:

对SAH药物治疗现有数据的文献综述.
分析最近的临床试验和新出现的证据.
综合关于既有和新型治疗方法的信息.

主要成果:

尼莫迪平仍然是血管的唯一基于证据的治疗方法.
新型药物如硫酸,西洛斯塔,克拉索森坦和法苏迪尔显示出有前途的结果.
抗纤维解质疗法可能会降低死亡率;抗凝固剂可能会降低延迟脑缺血症.
三重H疗法的疗效仍有争议,需要进一步证据来确定最佳疗法.
类他类药物可以通过减少血管和延迟缺血事件来提供好处.

结论:

对SAH的药物治疗环境充满活力,正在进行的研究产生了新的潜在治疗方法.
虽然尼莫迪平已建立,但新的药物和策略正在扩大SAH的治疗选择.
预计进一步的临床试验将为治疗SAH的医生提供更多的治疗选择.

关键词:

甲状腺下下垂体出血延迟大脑缺血症的发生死亡率. 死亡率. 在死亡率.结果结果结果结果.药物治疗药物治疗治疗疗法治疗疗法治疗疗法这是一种血管.

更多相关视频

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation

Published on: October 15, 2021

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Published on: August 30, 2020

相关概念视频

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...